Simon Robson

Dr. Simon Robson is a physician scientist. He received his Medical degree in Internal Medicine and PhD in Internal Medicine from the University of Cape Town, South Africa. After serving as the Chief Medical Scientist and Deputy Director of the Medical Research Council of the Liver Center at the University of Cape Town Dr. Robson joined the Faculty of Medicine at Harvard Medical School in 1996. From 2012 to 2015 Dr. Robson served as the Chief of Gastroenterology, Hepatology & Endoscopy at BIDMC. At BIDMC, he holds the title of Director of Liver Research within the Division of Gastroenterology and has been a core faculty member of the Transplant Institute.

Since 1996 Dr. Robson's research program has been continuously funded by grants from NIH, the DoD, AASLD, AHA and other national and international sources as well as biopharmaceutical industry. He has served as a standing charter member on NIH, AHA and other Study Sections. As a member of the AASLD Basic Research Committee, he has organized Liver Fibrosis Special Interest Group (SIG) programs. He is a thought leader in purinergic signaling area and served as the Chairman of Scientific Committees and International Workshops on Purinergic Signaling, as well as being an Associate Editor of several journals inclusive of "Purinergic Signalling."

While running a highly successful and robust research program he also remains active clinically in Hepatology and Liver Transplantation and cares for a diverse population of patients with inflammatory, autoimmune and vascular-type liver diseases; as well as those undergoing liver transplantation.

In 2018 Dr. Robson joined the Department of Anesthesia, Critical Care and Pain Medicine at BIDMC as the Director of the Center for Inflammation Research. In 2019 he was appointed to the position of the Vice Chair of Anesthesia Research.